<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did OVID's Q1 2025 EPS forecast compare to past surprises?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/9/2025 05:22pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Ovid Therapeutics (OVID) reported an EPS surprise of $0.04 for Q1 2025, which is a positive indicator as the actual EPS exceeded the forecast. However, the company's stock price decreased by 11.43%. This suggests that while the earnings beat may have been a positive factor for the stock, other factors such as market conditions or company-specific news could have led to the decline in stock price.


|code|Ticker|Name|Date|Estimate EPS|EPS Surprise|market_code|
|---|---|---|---|---|---|---|
|OVID|OVID.O|Ovid Therapeutics|2024 Q1|-0.22|0.05|185|
|OVID|OVID.O|Ovid Therapeutics|2024 Q2|-0.22|0.34|185|
|OVID|OVID.O|Ovid Therapeutics|2024 Q3|-0.21|0.01|185|
|OVID|OVID.O|Ovid Therapeutics|2024 Q4|-0.17|0.04|185|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:S,comeFrom:"AInvestShareLink",events:[],answerSource:p}],fetch:{},error:q,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:h,agent_id:a,output_media_info:[],task_id:a,language:a,source:p,cache_builder:a,reply_action:"Answer",execute_mode:H,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did OVID's Q1 2025 EPS forecast compare to past surprises?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did OVID's Q1 2025 EPS forecast compare to past surprises?\",\"user_id\":\"dp58191527\",\"user_name\":\"\",\"trace_id\":\"bb57d156-4f3b-4fef-b71d-43073ec0f22b\",\"session_id\":\"bb57d156-4f3b-4fef-b71d-43073ec0f22b\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:j,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|EPS Surprise[20241231]|Report End Date|Diluted EPS (MRQ)|Latest Report Period|Latest Report End Date|\n|---|---|---|---|---|---|---|---|---|\n|OVID|Ovid Therapeutics|$0.26|-11.43%|0.04|20241231||2024Q4|20241231|\n",query_data:{number:h,title:I,query_type:j,condition:a,model_sql:T,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:e}}}],answer_chain_name:U,agent_mode:V,native_answer:a,come_from:a,text_answer:S,trace_id:i,cost:14182,event_names:a,question:g,fallback_type:W,input_type:X,fall_back_reason:{fall_back_type:W,risk_detail:{matched_words:[]}},session_id:i,first_return_cost:2372,cache_type:a,question_id:i,transfer_question:g,signal_type:"ON_COMPLETE",start_time:Y,remote_svc:p,slots:[],answer_type:H,user_id:z,skill_name:J},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:z,question:g,source:p,raw_question:g,version:"3.4.1",action_name:J,nlu:{entity:[{type:Z,value:r,market:k}]},deep_research:c,deep_thinking:c,agent_mode:V},extra:{}},{answer_path:A,section:{id:B,info_texts:["Thinking"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:A,section:{id:B,info_texts:["Querying Stock: OVID EPS Surprise, EPS"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:I,thought:"The user wants to compare OVID's Q1 2025 EPS forecast surprise with previous ones. I should focus on OVID's Q1 2025 EPS forecast and its surprise. I will use FinQuery for the data mentioned above."}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:A,section:{id:B,info_texts:["Generating Answer"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:"O",text_answer:_,rich_text:_,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:t,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:I,query_type:j,trace_data:a,index:h,model_sql:T,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:e},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:". This",text_answer:$,rich_text:$,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:u,market_id:k,name:n,domain:Z},pos:e,section_id:m,txt:n,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:"\n",text_answer:aa,rich_text:aa,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:ab,choice:[],result_page:{components:[{uuid:"9f0ad12a18404b9d",config:{score:115,show_type:ac,scoreRuleNames:"value_unit;",showDataZoom:b,show_type_id:303,title:"分组折线图",render:{x:v,y:[D,E]},title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ad,h2:a},show_type:K}},data:{chunks_info:"[]",code_count:h,columns:[{index_name:L,key:L,label:"hq_code",source:M,type:f},{domain:F,feKey:N,index_name:N,key:N,label:L,origin_index:"stock code",source:M,type:f,unit:a},{domain:F,feKey:O,index_name:O,key:O,label:"name",origin_index:"stock name",source:M,type:f,unit:a},{feKey:v,index_name:v,key:v,label:"date",origin_index:v,type:"DATE"},{domain:F,feKey:D,index_name:D,key:D,label:a,source:a,timestamp:a,type:ae,unit:a},{domain:F,feKey:E,index_name:E,key:E,label:a,source:a,timestamp:a,type:ae,unit:a},{index_name:af,key:af,type:f}],condition:"[{\"sonSize\":4,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL OVID.O\"],\"indexPropertiesMap\":{\"EQUAL\":\"OVID.O\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":2,\"opName\":\"or\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Estimate EPS\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@EPS Surprise\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:4,datas:[{code:u,"Estimate EPS":ag,Ticker:r,"EPS Surprise":.05,market_code:k,Date:"2024 Q1",Name:n},{code:u,"Estimate EPS":ag,Ticker:r,"EPS Surprise":.34,market_code:k,Date:"2024 Q2",Name:n},{code:u,"Estimate EPS":-.21,Ticker:r,"EPS Surprise":.01,market_code:k,Date:"2024 Q3",Name:n},{code:u,"Estimate EPS":-.17,Ticker:r,"EPS Surprise":.04,market_code:k,Date:"2024 Q4",Name:n}],meta:{extra:{}},row_count:h,status_code:e,status_msg:"ok"},category:"generic",chart_type:"groupedLine",show_type:ac,title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ad,h2:a},show_type:K},support_refresh:b,data_config:{query:a,query_type:j,data_ext_params:{}}}],global:{query_type:j},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"line3\",\"uuid\":\"9f0ad12a18404b9d\"}]"},render_for:P},data_config:{query:a,query_type:j,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"e19a8490-8838-4e3d-9e92-696caae4f966"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:A,section:{id:B,info_texts:["Completed"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:ab,choice:[{display_text:w,query_text:w,trace_info:{item_id:"1dca19b636a1e6f7d5144cb56a0a032e",item_type:o,item_name:w,rec_info:ah}},{display_text:x,query_text:x,trace_info:{item_id:"3d2f751285cea4dcde45e106432d5048",item_type:o,item_name:x,rec_info:ai}},{display_text:y,query_text:y,trace_info:{item_id:"4e96fd00004be78286024a2a63c32a68",item_type:o,item_name:y,rec_info:aj}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:K,data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:ak,related_name:al}],puuid:Q,tag:a,category:"custom",uuid:am}],global:{urp_static_data:[{name:al,value:{status_code:e,columns:[{type:f,index_name:an,key:an},{type:f,index_name:ao,key:ao},{type:f,index_name:ap,key:ap},{type:f,index_name:aq,key:aq},{type:f,index_name:ar,key:ar}],datas:[{send_text:w,item_type:o,rec_info:ah,display_text:w,rec_reason:a},{send_text:x,item_type:o,rec_info:ai,display_text:x,rec_reason:a},{send_text:y,item_type:o,rec_info:aj,display_text:y,rec_reason:a}],dataSize:ak,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:as,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:G,"min-height":"100%",position:at,height:G},isMaterial:c,id:as,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:R,componentUuid:am,script:[{name:au,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:R,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:R},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:G,position:at,height:G},isMaterial:b,_id:19,id:au,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:P,voice_txt:a,tracking_info:{},uuid:Q},order:{is_auto:c,render_for:P,chart_type:"command",puuid:Q}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:J,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:H,answer_chain_name:U},is_deep_research:c,deep_thinking:c,create_time:1744190559812},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:q,docsData:[],quoteData:q},tplType:"question"},events:av,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:av,client_ip:a,question:g,user_id:z,user_name:a,trace_id:i,session_id:i,source:p,input_type:X}}],userId:z,userName:a,startTime:Y,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:q,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:q,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fovids-q1-2025-eps-forecast-compare-surprises-d9a585\u002F",config:{_app:{basePath:aw,assetsPath:aw,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,"STR","How did OVID's Q1 2025 EPS forecast compare to past surprises?",1,"bb57d156-4f3b-4fef-b71d-43073ec0f22b","intusstock","185","signal",2001,"Ovid Therapeutics","llm_generated","ths_ainvest_lite_web",null,"OVID.O",999,"rich_text","OVID","Date","What were OVID's actual EPS for the past three quarters?","How have analysts adjusted their EPS estimates for OVID in the last month?","What are the technical indicators suggesting for OVID's stock price in the near term?","dp58191527","progress\u002Fsearching_for",1000,"searching_for","Estimate EPS","EPS Surprise","abs_国际美股领域","auto","agent","OVID EPS Surprise, EPS","review stocks","title1","code","fixed_index","Ticker","Name","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Ovid Therapeutics (OVID) reported an EPS surprise of $0.04 for Q1 2025, which is a positive indicator as the actual EPS exceeded the forecast. However, the company's stock price decreased by 11.43%. This suggests that while the earnings beat may have been a positive factor for the stock, other factors such as market conditions or company-specific news could have led to the decline in stock price.\n\n\n|code|Ticker|Name|Date|Estimate EPS|EPS Surprise|market_code|\n|---|---|---|---|---|---|---|\n|OVID|OVID.O|Ovid Therapeutics|2024 Q1|-0.22|0.05|185|\n|OVID|OVID.O|Ovid Therapeutics|2024 Q2|-0.22|0.34|185|\n|OVID|OVID.O|Ovid Therapeutics|2024 Q3|-0.21|0.01|185|\n|OVID|OVID.O|Ovid Therapeutics|2024 Q4|-0.17|0.04|185|\n\n","select   stock_code,   eps_surprise from   ustock_fin_forecast where   stock_code = 'OVID.O' intersect select   stock_code,   diluted_eps from   ustock_fin_data where   stock_code = 'OVID.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1744190545630,"stock","Ovid Therapeutics (OVID) reported an EPS surprise of $0.04 for Q1 2025, which is a positive indicator as the actual EPS exceeded the forecast. However, the company's stock price decreased by 11.43%[^1]",". This suggests that while the earnings beat may have been a positive factor for the stock, other factors such as market conditions or company-specific news could have led to the decline in stock price.\n\n","\n``` visual\n{\"uuid\":\"e19a8490-8838-4e3d-9e92-696caae4f966\"}\n```","result_page","line3","OVID Estimate EPS, EPS Surprise","DOUBLE","market_code",-.22,"2+679_496_21_554+0+0+bb57d156-4f3b-4fef-b71d-43073ec0f22b+1dca19b636a1e6f7d5144cb56a0a032e+llm_generated+aimeTagAnalysis+0+0.08308201283216476+1","2+679_496_21_554+0+0+bb57d156-4f3b-4fef-b71d-43073ec0f22b+3d2f751285cea4dcde45e106432d5048+llm_generated+aimeTagAnalysis+0+0.06006317213177681+2","2+679_496_21_554+0+0+bb57d156-4f3b-4fef-b71d-43073ec0f22b+4e96fd00004be78286024a2a63c32a68+llm_generated+aimeTagAnalysis+0+0.05522758886218071+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>